In addition to the traditional evaluation tools of the model for end-stage liver disease (MELD) score (2) or the Child-Turcotte-Pugh (CTP) classification (3), an alternative measure of liver function based solely on albumin and bilirubin, the albumin-bilirubin (ALBI) score, was proposed in international collaboration as a simple and objective method for the assessment of liver function in patients with hepatocellular carcinoma (4). The gene discussed is ALB; the disease is End Stage Liver Disease.